Author:
Cserne Szappanos Henrietta,Viola Helena M.,Ito Danica W.,Lim Seakcheng,Mangala Melissa,Holliday Mira,Barratt Ross Samantha,Semsarian Christopher,Hill Adam,Dixon Rose E.,Hool Livia C.
Abstract
AbstractFamilial hypertrophic cardiomyopathy (FHC) patients are advised to avoid strenuous exercise due to increased risk of arrhythmias. Mice expressing the human FHC-causing mutation R403Q in the myosin heavy chain gene (MYH6) recapitulate the human phenotype, including cytoskeletal disarray and increased arrhythmia susceptibility. Following in vivo administration of isoproterenol, mutant mice exhibited tachyarrhythmias, poor recovery and fatigue. Arrhythmias were attenuated with the β-blocker atenolol and protein kinase A inhibitor PKI. Mutant cardiac myocytes had significantly prolonged action potentials and triggered automaticity due to reduced repolarization reserve and connexin 43 expression. Isoproterenol shortened cycle length, and escalated electrical instability. Surprisingly isoproterenol did not increase CaV1.2 current. We found alterations in CaV1.2-β1 adrenergic receptor colocalization assessed using super-resolution nanoscopy, and increased CaV1.2 phosphorylation in mutant hearts. Our results reveal for the first time that altered ion channel expression, co-localization and β-adrenergic receptor signaling associated with myocyte disarray contribute to electrical instability in the R403Q mutant heart.
Funder
National Heart Foundation of Australia
National Institutes of Health
National Health and Medical Research Council
National Health and Medical Research Council of Australia
National Institutes Award
American Heart Association
Woodside
Wesfarmers Company
Publisher
Springer Science and Business Media LLC